• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便潜血试验在韩国国家癌症筛查计划中的有效性。

Validity of fecal occult blood test in the national cancer screening program, Korea.

机构信息

Molecular Epidemiology Branch, Research Institute, National Cancer Center, Goyang-si, Korea ; Cancer Registration & Statistics Branch, National Cancer Control Institute, National Cancer Center, Goyang-si, Korea.

出版信息

PLoS One. 2013 Nov 8;8(11):e79292. doi: 10.1371/journal.pone.0079292. eCollection 2013.

DOI:10.1371/journal.pone.0079292
PMID:24260189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3832630/
Abstract

AIM

The aims of the current study were to assess the validity of the fecal occult blood test (FOBT) in an organized screening setting in Korea and to determine factors associated with FOBT validity, such as screening round, age group, and anatomical location of the cancer.

METHODS

Study participants were those who were 50 years and older who received an FOBT through the National Cancer Screening Program between 2004 and 2007. Colorectal cancer diagnoses were ascertained through linkage with the Korean National Cancer Incidence Database. The positivity rate, colorectal cancer detection rate, interval cancer rate, sensitivity, specificity, and positive predictive value of the FOBT were calculated.

RESULTS

A total of 2,193,093 tests were included in the analysis. Overall, the sensitivity of the FOBT for colorectal cancer was 59.7% for the first round and 56.1% for the subsequent round. Sensitivity was highest for distal colon cancer (65.9%) in the first round, and for rectal cancer (58.4%) for the subsequent round. The sensitivity and positive predictive value of the FOBT generally improved between 2004 and 2008.

CONCLUSIONS

The FOBT showed reasonable validity in an organized screening setting, and the validity of the FOBT varied by screening round, anatomical location, and screening year.

摘要

目的

本研究旨在评估在韩国有组织的筛查环境中粪便潜血试验(FOBT)的有效性,并确定与 FOBT 有效性相关的因素,如筛查轮次、年龄组和癌症的解剖位置。

方法

研究对象为 2004 年至 2007 年间通过国家癌症筛查计划接受 FOBT 的 50 岁及以上人群。通过与韩国国家癌症发病率数据库的链接确定结直肠癌的诊断。计算 FOBT 的阳性率、结直肠癌检出率、间期癌率、敏感性、特异性和阳性预测值。

结果

共纳入 2193093 例检测。总体而言,FOBT 对结直肠癌的敏感性在第一轮为 59.7%,第二轮为 56.1%。第一轮时,远端结肠癌(65.9%)和第二轮时,直肠(58.4%)的敏感性最高。FOBT 的敏感性和阳性预测值在 2004 年至 2008 年间普遍提高。

结论

FOBT 在有组织的筛查环境中具有合理的有效性,FOBT 的有效性因筛查轮次、解剖位置和筛查年份而异。

相似文献

1
Validity of fecal occult blood test in the national cancer screening program, Korea.粪便潜血试验在韩国国家癌症筛查计划中的有效性。
PLoS One. 2013 Nov 8;8(11):e79292. doi: 10.1371/journal.pone.0079292. eCollection 2013.
2
Fecal Occult Blood Test Results of the National Colorectal Cancer Screening Program in South Korea (2006-2013).韩国国家结直肠癌筛查计划(2006-2013 年)粪便潜血试验结果。
Sci Rep. 2017 Jun 5;7(1):2804. doi: 10.1038/s41598-017-03134-9.
3
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.用于结直肠癌筛查的粪便潜血试验:一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.
4
Divergent Long-Term Detection Rates of Proximal and Distal Advanced Neoplasia in Fecal Immunochemical Test Screening Programs: A Retrospective Cohort Study.粪便免疫化学检测筛查项目中近端和远端晚期腺瘤的长期检出率差异:一项回顾性队列研究。
Ann Intern Med. 2018 Nov 6;169(9):602-609. doi: 10.7326/M18-0855. Epub 2018 Oct 2.
5
Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).克罗地亚国家结直肠癌筛查计划的结果(2007-2011 年)。
World J Gastroenterol. 2012 Aug 28;18(32):4300-7. doi: 10.3748/wjg.v18.i32.4300.
6
Contribution of the OC Sensor immunoassay in comparison to the Hemoccult II guaiac-test in organized colorectal cancer screening.OC 传感器免疫测定与 Hemoccult II 愈创木脂检测在有组织的结直肠癌筛查中的比较。
Eur J Epidemiol. 2019 Feb;34(2):163-172. doi: 10.1007/s10654-018-0471-z. Epub 2018 Dec 8.
7
Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.粪便检测阴性的结直肠癌患者发生高级别腺瘤风险较低。
Gastroenterology. 2012 Mar;142(3):497-504. doi: 10.1053/j.gastro.2011.11.024. Epub 2011 Nov 19.
8
Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.2004-2008 年韩国在有组织的结直肠癌筛查项目中对粪便潜血检测阳性后的随访依从性。
J Gastroenterol Hepatol. 2012 Jun;27(6):1070-7. doi: 10.1111/j.1440-1746.2011.06944.x.
9
Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.使用新型粪便潜血试验筛查结直肠肿瘤:性能特征的最新进展。
J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70. doi: 10.1093/jnci/djm150. Epub 2007 Sep 25.
10
Risk of Interval Cancer in Fecal Immunochemical Test Screening Significantly Higher During the Summer Months: Results from the National Cancer Screening Program in Korea.粪便免疫化学试验筛查夏季间隔期癌症风险显著升高:来自韩国国家癌症筛查计划的结果。
Am J Gastroenterol. 2018 Apr;113(4):611-621. doi: 10.1038/ajg.2018.23. Epub 2018 Mar 6.

引用本文的文献

1
Colon lesions in elderly individuals with positive and negative fecal immunochemical test results among PERSIAN Guilan cohort study (PGCS) population.波斯湾吉兰队列研究(PGCS)人群中粪便免疫化学检测结果呈阳性和阴性的老年个体的结肠病变
Caspian J Intern Med. 2025 Dec 24;16(3):451-457. doi: 10.22088/cjim.16.3.451. eCollection 2025 Summer.
2
Effectiveness of the Korean National Cancer Screening Program in Reducing Colorectal Cancer Mortality.韩国国家癌症筛查计划在降低结直肠癌死亡率方面的有效性。
Cancers (Basel). 2024 Dec 23;16(24):4278. doi: 10.3390/cancers16244278.
3
Association between Endoscopist Volume and Interval Cancers after Colonoscopy: Results from the National Colorectal Cancer Screening Program in Korea.内镜医师工作量与结肠镜检查后间期癌症的关系:来自韩国国家结直肠癌筛查计划的结果。
Cancer Res Treat. 2024 Oct;56(4):1164-1170. doi: 10.4143/crt.2024.009. Epub 2024 Apr 16.
4
National cancer screening program for colorectal cancer in Korea.韩国的国家结直肠癌筛查计划。
Ann Surg Treat Res. 2023 Dec;105(6):333-340. doi: 10.4174/astr.2023.105.6.333. Epub 2023 Nov 29.
5
Positive faecal immunochemical test predicts the onset of inflammatory bowel disease: A nationwide, propensity score-matched study.便免疫化学检测阳性可预测炎症性肠病的发病:一项全国性、倾向评分匹配研究。
Front Immunol. 2023 Feb 13;14:1128736. doi: 10.3389/fimmu.2023.1128736. eCollection 2023.
6
A positive faecal immunochemical test result and its association with the incidence of rheumatoid arthritis, systemic lupus erythematosus, and psoriatic arthritis: an analysis of one-million national colorectal cancer screening programme results.粪便免疫化学检测阳性结果及其与类风湿关节炎、系统性红斑狼疮和银屑病关节炎发病的相关性:一项百万人全国结直肠癌筛查计划结果分析。
BMC Med. 2022 Jul 4;20(1):226. doi: 10.1186/s12916-022-02416-y.
7
Findings from the first colorectal cancer screening among 103 542 individuals in Vietnam with systematic review of colorectal cancer screening programs in Asia-Pacific region.越南 103542 例人群的首次结直肠癌筛查结果,以及对亚太地区结直肠癌筛查计划的系统评价。
Jpn J Clin Oncol. 2022 Jul 8;52(7):707-715. doi: 10.1093/jjco/hyac043.
8
Optimizing the colorectal cancer screening programme using faecal immunochemical test (FIT) in Flanders, Belgium from the "interval cancer" perspective.从“间期癌”角度优化比利时佛兰德斯的粪便免疫化学试验(FIT)结直肠癌筛查方案。
Br J Cancer. 2022 Apr;126(7):1091-1099. doi: 10.1038/s41416-021-01694-2. Epub 2022 Jan 12.
9
Risk-stratified colorectal cancer screening for optimal use of colonoscopy resources.基于风险分层的结直肠癌筛查,以优化结肠镜检查资源的利用。
Korean J Intern Med. 2021 Jul;36(4):839-841. doi: 10.3904/kjim.2021.288. Epub 2021 Jul 1.
10
Use of Antiplatelet Agents Decreases the Positive Predictive Value of Fecal Immunochemical Tests for Colorectal Cancer but Does Not Affect Their Sensitivity.抗血小板药物的使用降低了粪便免疫化学检测对结直肠癌的阳性预测值,但不影响其敏感性。
J Pers Med. 2021 Jun 1;11(6):497. doi: 10.3390/jpm11060497.

本文引用的文献

1
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2009.韩国癌症统计数据:2009 年的发病率、死亡率、生存率和患病率。
Cancer Res Treat. 2012 Mar;44(1):11-24. doi: 10.4143/crt.2012.44.1.11. Epub 2012 Mar 31.
2
A comparison of qualitative and quantitative fecal immunochemical tests in the Korean national colorectal cancer screening program.韩国全国结直肠癌筛查项目中定性和定量粪便免疫化学检测的比较
Scand J Gastroenterol. 2012 Apr;47(4):461-6. doi: 10.3109/00365521.2012.668930.
3
Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.2004-2008 年韩国在有组织的结直肠癌筛查项目中对粪便潜血检测阳性后的随访依从性。
J Gastroenterol Hepatol. 2012 Jun;27(6):1070-7. doi: 10.1111/j.1440-1746.2011.06944.x.
4
Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site.基于粪便潜血试验的结直肠癌人群筛查项目中的间期癌:对分期、性别和肿瘤部位的影响。
Gut. 2012 Apr;61(4):576-81. doi: 10.1136/gutjnl-2011-300535. Epub 2011 Sep 19.
5
Is fecal occult blood testing more sensitive for left- versus right-sided colorectal neoplasia? A systematic literature review.便潜血检测对于左、右侧结直肠肿瘤的检测敏感性更高吗?系统文献回顾。
Expert Rev Mol Diagn. 2011 Jul;11(6):605-16. doi: 10.1586/erm.11.41.
6
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008.韩国癌症统计数据:2008 年的发病率、死亡率、生存率和患病率。
Cancer Res Treat. 2011 Mar;43(1):1-11. doi: 10.4143/crt.2011.43.1.1. Epub 2011 Mar 31.
7
Long-term trends in cancer mortality in Korea (1983-2007): a joinpoint regression analysis.韩国癌症死亡率的长期趋势(1983 - 2007年):连接点回归分析
Asian Pac J Cancer Prev. 2010;11(6):1451-7.
8
Comparison of immunochemical and guaiac-based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: a meta-analysis.免疫化学法和愈创木脂法粪便隐血试验在筛查和监测结直肠高级别瘤变中的比较:一项荟萃分析。
J Dig Dis. 2010 Jun;11(3):148-60. doi: 10.1111/j.1751-2980.2010.00430.x.
9
Comparison of guaiac-based and quantitative immunochemical fecal occult blood testing in a population at average risk undergoing colorectal cancer screening.在平均风险的结直肠癌筛查人群中,基于愈创木脂的和定量免疫化学粪便隐血检测的比较。
Am J Gastroenterol. 2010 Sep;105(9):2017-25. doi: 10.1038/ajg.2010.179. Epub 2010 May 25.
10
Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening.美国 2010 年癌症筛查:对现行美国癌症协会指南的回顾以及癌症筛查中的问题。
CA Cancer J Clin. 2010 Mar-Apr;60(2):99-119. doi: 10.3322/caac.20063.